In addition, its targets gene in AIM includes inflammatory markers such as IL18, CD68, TYPOBP, and AD risk genes such as ARHGAP45 and APOC1 (Xue et al., 2021; Kulminski et al., 2022). The gene discussed is IL18; the disease is Alzheimer disease.